Antibodies: A-Alpha Bio

About this session

A-Alpha Bio is a biotechnology platform company that measures, predicts, and engineers protein-protein interactions at scale. Its experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Its AI platform, AlphaBind, is trained on the world's largest protein-protein interaction database and predicts binding strength from sequence.

Speaker

• DY

  David Younger

  CEO & Co-Founder · A-Alpha Bio

  Speaker